Margunato-Debay S - Search Results

1

Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis.

Cortes J, Pérez-García J, Whiting S, Wan Y, Solem C, Tai MH, Margunato-Debay S, Ko A, Fandi A, Botteman M. Cortes J, et al. Among authors: margunato debay s. Clin Breast Cancer. 2018 Oct;18(5):e919-e926. doi: 10.1016/j.clbc.2018.03.014. Epub 2018 Mar 30. Clin Breast Cancer. 2018. PMID: 29703690 Free article.

2

Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin.

Hirsh V, Wan Y, Lin FJ, Margunato-Debay S, Ong TJ, Botteman M, Langer C. Hirsh V, et al. Among authors: margunato debay s. Clin Lung Cancer. 2018 Sep;19(5):401-409.e4. doi: 10.1016/j.cllc.2018.04.023. Epub 2018 May 7. Clin Lung Cancer. 2018. PMID: 29903552 Free article.

3

Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer.

Chiorean EG, Von Hoff D, Wan Y, Margunato-Debay S, Botteman M, Goldstein D. Chiorean EG, et al. Among authors: margunato debay s. Cancer Manag Res. 2018 May 31;10:1389-1396. doi: 10.2147/CMAR.S163475. eCollection 2018. Cancer Manag Res. 2018. PMID: 29910636 Free PMC article.

4

nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial.

Young R, Mainwaring P, Clingan P, Parnis FX, Asghari G, Beale P, Aly A, Botteman M, Romano A, Ferrara S, Margunato-Debay S, Harris M. Young R, et al. Among authors: margunato debay s. Asia Pac J Clin Oncol. 2018 Oct;14(5):e325-e331. doi: 10.1111/ajco.12999. Epub 2018 Jun 22. Asia Pac J Clin Oncol. 2018. PMID: 29932294 Clinical Trial.

5

Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer.

Goldstein D, Von Hoff DD, Chiorean EG, Reni M, Tabernero J, Ramanathan RK, Botteman M, Aly A, Margunato-Debay S, Lu B, Louis CU, McGovern D, Lee CK. Goldstein D, et al. Among authors: margunato debay s. Pancreas. 2020 Jul;49(6):744-750. doi: 10.1097/MPA.0000000000001563. Pancreas. 2020. PMID: 32541630 Free PMC article.

6

Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxane-based Chemotherapy for Stage IV Non-Small-cell Lung Cancer in a US Community Oncology Setting.

Weiss J, Force RW, Pugmire BA, Peterson T, Faria C, Margunato-Debay S, Patel MB. Weiss J, et al. Among authors: margunato debay s. Clin Lung Cancer. 2017 Jul;18(4):372-380.e1. doi: 10.1016/j.cllc.2016.12.008. Epub 2016 Dec 22. Clin Lung Cancer. 2017. PMID: 28117221

7

Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting.

Mudad R, Patel MB, Margunato-Debay S, Garofalo D, Lal LS. Mudad R, et al. Among authors: margunato debay s. Lung Cancer (Auckl). 2017 Oct 19;8:179-190. doi: 10.2147/LCTT.S139647. eCollection 2017. Lung Cancer (Auckl). 2017. PMID: 29089791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters